Rho kinase inhibitor enables cell-based therapy for corneal endothelial dysfunction
Naoki Okumura(Doshisha University), Noriko Koizumi(Doshisha University)
Cited by 181
Related Papers
Growth factor mRNA and protein in preserved human amniotic membrane
|Current Eye Research|2000|629
Injection of Cultured Cells with a ROCK Inhibitor for Bullous Keratopathy
|New England Journal of Medicine|2018|551
Cultivated corneal epithelial stem cell transplantation in ocular surface disorders
|Ophthalmology|2001|483
New Grading System for the Evaluation of Chronic Ocular Manifestations in Patients with Stevens–Johnson Syndrome
|Ophthalmology|2007|311
Midterm Results on Ocular Surface Reconstruction Using Cultivated Autologous Oral Mucosal Epithelial Transplantation
|American Journal of Ophthalmology|2006|212